Janneke P Bil1, Udi Davidovich, Wendy M van der Veldt, Maria Prins, Henry J C de Vries, Gerard J B Sonder, Ineke G Stolte. 1. aDepartment of Infectious Diseases Research and Prevention, Public Health Service Amsterdam bDepartment of Infectious Diseases, Center for Infection and Immunology Amsterdam (CINIMA), Academic Medical Center (AMC), University of Amsterdam cSTI Outpatient Clinic, Public Health Service Amsterdam dDepartment of Dermatology, Academic Medical Center (AMC), University of Amsterdam eDepartment of Infectious Diseases, Public Health Service of Amsterdam fDivision of Infectious Diseases, Department of Internal Medicine, Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands.
Abstract
OBJECTIVES: Although preexposure prophylaxis (PrEP) is not registered in Europe, including the Netherlands, its approval and implementation are expected in the near future. We aimed to gain insight into PrEP awareness and the intention to use PrEP among MSM. DESIGN: Cross-sectional study among 448 HIV-negative participants of the Amsterdam Cohort Study who completed a questionnaire concerning behavior and PrEP between 2012 and 2013. METHODS: Characteristics, PrEP awareness, and intention to use PrEP were described and multinomial logistic regression was used to identify determinants of a medium and high intention to use PrEP. RESULTS: PrEP awareness was 54%, but only 13% reported a high intention to use PrEP. High-risk MSM were more likely to have a medium [adjusted odds ratio (aOR): 1.78 (95% confidence interval [CI] 1.07-2.97)] or high [aOR: 3.92 (95% CI 1.68-9.15)] intention to use PrEP than low-risk MSM, as were MSM with higher perceptions of self-efficacy to use PrEP [high intention: aOR: 6.15 (95% CI 2.50-15.09)] and higher perceptions of relief due to PrEP [medium intention: aOR: 2.67 (95% CI 1.32-5.40); high intention: aOR: 14.87 (95% CI 5.98-37.01)] than MSM with lower perceptions. MSM with higher perceptions of shame about using PrEP [medium intention: aOR: 0.35 (95% CI 0.19-0.62); high intention: aOR: 0.22 (95% CI 0.07-0.71)] or with more worries about side-effects were less likely to have a high [aOR: 0.18 (95% CI 0.06-0.54)] or medium [aOR: 0.29 (95% CI 0.12-0.72)] intention to use PrEP. CONCLUSION: The overall intention to use PrEP was relatively low, but higher among high-risk MSM. If PrEP implementation among high-risk MSM in the Netherlands becomes reality, PrEP awareness should be increased and psychosocial determinants that will influence uptake should be addressed.
OBJECTIVES: Although preexposure prophylaxis (PrEP) is not registered in Europe, including the Netherlands, its approval and implementation are expected in the near future. We aimed to gain insight into PrEP awareness and the intention to use PrEP among MSM. DESIGN: Cross-sectional study among 448 HIV-negative participants of the Amsterdam Cohort Study who completed a questionnaire concerning behavior and PrEP between 2012 and 2013. METHODS: Characteristics, PrEP awareness, and intention to use PrEP were described and multinomial logistic regression was used to identify determinants of a medium and high intention to use PrEP. RESULTS: PrEP awareness was 54%, but only 13% reported a high intention to use PrEP. High-risk MSM were more likely to have a medium [adjusted odds ratio (aOR): 1.78 (95% confidence interval [CI] 1.07-2.97)] or high [aOR: 3.92 (95% CI 1.68-9.15)] intention to use PrEP than low-risk MSM, as were MSM with higher perceptions of self-efficacy to use PrEP [high intention: aOR: 6.15 (95% CI 2.50-15.09)] and higher perceptions of relief due to PrEP [medium intention: aOR: 2.67 (95% CI 1.32-5.40); high intention: aOR: 14.87 (95% CI 5.98-37.01)] than MSM with lower perceptions. MSM with higher perceptions of shame about using PrEP [medium intention: aOR: 0.35 (95% CI 0.19-0.62); high intention: aOR: 0.22 (95% CI 0.07-0.71)] or with more worries about side-effects were less likely to have a high [aOR: 0.18 (95% CI 0.06-0.54)] or medium [aOR: 0.29 (95% CI 0.12-0.72)] intention to use PrEP. CONCLUSION: The overall intention to use PrEP was relatively low, but higher among high-risk MSM. If PrEP implementation among high-risk MSM in the Netherlands becomes reality, PrEP awareness should be increased and psychosocial determinants that will influence uptake should be addressed.
Authors: Gianluca Voglino; Maria Rosaria Gualano; Stefano Rousset; Pietro Forghieri; Isabella Fraire; Fabrizio Bert; Roberta Siliquini Journal: Int J Environ Res Public Health Date: 2021-04-29 Impact factor: 3.390
Authors: Thiago Silva Torres; Raquel Brandini De Boni; Mauricio Tl de Vasconcellos; Paula Mendes Luz; Brenda Hoagland; Ronaldo Ismerio Moreira; Valdilea Gonçalves Veloso; Beatriz Grinsztejn Journal: JMIR Public Health Surveill Date: 2018-01-22
Authors: Oliver Ratmann; Ard van Sighem; Daniela Bezemer; Alexandra Gavryushkina; Suzanne Jurriaans; Annemarie Wensing; Frank de Wolf; Peter Reiss; Christophe Fraser Journal: Sci Transl Med Date: 2016-01-06 Impact factor: 17.956
Authors: Janneke P Bil; Wendy M van der Veldt; Maria Prins; Ineke G Stolte; Udi Davidovich Journal: Medicine (Baltimore) Date: 2016-09 Impact factor: 1.889
Authors: Elske Hoornenborg; Roel Ca Achterbergh; Maarten F Schim van der Loeff; Udi Davidovich; Jannie J van der Helm; Arjan Hogewoning; Yvonne Thp van Duijnhoven; Gerard Jb Sonder; Henry Jc de Vries; Maria Prins Journal: J Int AIDS Soc Date: 2018-03 Impact factor: 5.396
Authors: Sin How Lim; Gitau Mburu; Adam Bourne; Joselyn Pang; Jeffrey A Wickersham; Clayton Koh Thuan Wei; Ilias Adam Yee; Bangyuan Wang; Matteo Cassolato; Iskandar Azwa Journal: PLoS One Date: 2017-09-13 Impact factor: 3.240
Authors: Janneke P Bil; Elske Hoornenborg; Maria Prins; Arjan Hogewoning; Fernando Dias Goncalves Lima; Henry J C de Vries; Udi Davidovich Journal: Front Public Health Date: 2018-02-09